Drugs by condition
Drugs approved for ulcerative colitis
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
59
Still marketed, NDA or BLA
Drug classes
8
Novel drugs
17
New molecular entities and new biologics
In development
40+
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for ulcerative colitis.
- Starjemza (Ustekinumab-Hmny) · Bio-Thera Solutions LTD May 22, 2025
- Otulfi (Ustekinumab-Aauz) · Fresenius Kabi USA Apr 30, 2025
- Pyzchiva (Ustekinumab-Ttwe) · Samsung Bioepis CO LTD Apr 30, 2025
- Steqeyma (Ustekinumab-Stba) · Celltrion, Inc. Dec 17, 2024
- Imuldosa (Ustekinumab-Srlf) · Accord Biopharma Inc. Oct 10, 2024
All approved drugs for ulcerative colitis, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 198 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Interleukin-12 Antagonist (9)
- Stelara Ustekinumab · Centocor Ortho Biotech INC · 2009
- Starjemza Ustekinumab-Hmny · Bio-Thera Solutions LTD · 2025
- Otulfi Ustekinumab-Aauz · Fresenius Kabi USA · 2025
- Pyzchiva Ustekinumab-Ttwe · Samsung Bioepis CO LTD · 2025
- Steqeyma Ustekinumab-Stba · Celltrion, Inc. · 2024
- Pyzchiva Ustekinumab-Ttwe · Samsung Bioepis CO LTD · 2024
- Wezlana Ustekinumab-Auub · Amgen INC · 2023
- Wezlana Ustekinumab-Auub · Amgen INC · 2023
- Stelara Ustekinumab · Janssen Biotech · 2016
Tumor Necrosis Factor Blocker (9)
- Simponi Golimumab · Centocor Ortho Biotech INC · 2009
- Remicade Infliximab · Centocor INC · 1998
- Yusimry Adalimumab-Aqvh · Emerge Bioscience Pte LTD · 2021
- Avsola Infliximab-Axxq · Amgen INC · 2019
- Hadlima Adalimumab-Bwwd · Samsung Bioepis CO LTD · 2019
- Hyrimoz Adalimumab-Adaz · Sandoz INC · 2018
- Renflexis Infliximab-Abda · Samsung Bioepis CO LTD · 2017
- Amjevita Adalimumab-Atto · Amgen INC · 2016
- Inflectra Infliximab-Dyyb · Celltrion INC · 2016
Corticosteroid (6)
Aminosalicylate (5)
- Rowasa Mesalamine · Mylan Speciality Lp · 1987
- Azulfidine En-Tabs Sulfasalazine · Pfizer · 1950
- Apriso Mesalamine · Salix · 2008
- Lialda Mesalamine · Takeda Pharms USA · 2007
- Pentasa Mesalamine · Takeda Pharms USA · 1993
Interleukin-23 Antagonist (4)
Janus Kinase Inhibitor (2)
Integrin Receptor Antagonist (2)
Class not listed in FDA's data (22)
- Velsipity Etrasimod Arginine · Pfizer · 2023
- Zeposia Ozanimod Hydrochloride · Bristol · 2020
- Xeljanz Tofacitinib Citrate · Pf Prism Cv · 2012
- Humira Adalimumab · Abbvie INC · 2002
- Dipentum Olsalazine Sodium · Mylan Spclt Viatris · 1990
- Celestone Soluspan Betamethasone Acetate, Betamethasone Sodium Phosphate · Organon · 1965
- Imuldosa Ustekinumab-Srlf · Accord Biopharma Inc. · 2024
- Selarsdi Ustekinumab-Aekn · Alvotech USA INC · 2024
- Simlandi Adalimumab-Ryvk · Alvotech USA INC · 2024
- Idacio Adalimumab-Aacf · Fresenius Kabi USA · 2024
- Zymfentra Infliximab-Dyyb · Celltrion · 2023
- Yuflyma Adalimumab-Aaty · Celltrion · 2023
- Xeljanz Tofacitinib Citrate · Pfizer · 2020
- Hulio Adalimumab-Fkjp · Mylan Pharms INC · 2020
- Abrilada Adalimumab-Afzb · Pfizer INC · 2019
- Cyltezo Adalimumab-Adbm · Boehringer Ingelheim · 2017
- Xeljanz Xr Tofacitinib Citrate · Pfizer · 2016
- Orapred Odt Prednisolone Sodium Phosphate · Advanz Pharma · 2006
- Pediapred Prednisolone Sodium Phosphate · Pai Holdings · 1986
- Depo-Medrol Methylprednisolone Acetate · Pfizer · 1959
- Solu-Medrol Methylprednisolone Sodium Succinate · Pharmacia and Upjohn · 1959
- Solu-Cortef Hydrocortisone Sodium Succinate · Pharmacia and Upjohn · 1955
Drugs in development for ulcerative colitis
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- ZasocitinibTAK- 279, NDI-034858Phase 317 trials
Takeda · Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease
- AfimkibartRO7790121, RVT-3101Phase 312 trials
Roche (Genentech) · Moderately to Severely Active Ulcerative Colitis, Moderately to Severely Active Crohns Disease, Atopic Dermatitis
- MK-7240PRA023, TulisokibartPhase 310 trials
Merck & Co. · Ulcerative Colitis, Psoriatic Arthritis, Crohn's Disease
- LutikizumabABT-981Phase 38 trials
AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis
- DuvakitugSAR447189, TEV-48574 APhase 36 trials
Sanofi · Ulcerative Colitis, Crohn's Disease, Hidradenitis
- FilgotinibGS-6034, GLPG0634Phase 36 trials
Alfasigma S.p.A. · Ulcerative Colitis, Polyarticular Course Juvenile Idiopathic Arthritis, Juvenile Idiopathic Arthritis (JIA)
- ABX464ObefazimodPhase 35 trials
Abivax S.A. · Ulcerative Colitis, Moderately to Severely Active Crohn Disease
- Hemay005Mufemilast, Phosphodiesterase 4 inhibitorsPhase 34 trials
Ganzhou Hemay Pharmaceutical Co., Ltd · Moderate to Severe Ulcerative Colitis, Ulcerative Colitis (UC), COPD (Chronic Obstructive Pulmonary Disease)
- brivekimigSAR442970Phase 25 trials
Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus
- SHR-1139Phase 25 trials
Guangdong Hengrui Pharmaceutical Co., Ltd · Moderate to Severe Plaque Psoriasis, Palmoplantar Pustulosis of Adults, Pyoderma Gangrenosum
- MORF-057zotemtegrast, LY4268989Phase 24 trials
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) · Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis (UC)
- IPG11406Phase 23 trials
Nanjing Immunophage Biotech Co., Ltd · Lupus Nephritis, Moderately to Severely Active Ulcerative Colitis (UC)
- ABBV-701Phase 22 trials
AbbVie · Crohn's Disease, Ulcerative Colitis, Psoriatic Arthritis
- anti-TL1A monoclonal antibodyPhase 22 trials
Biocad · Ulcerative Colitis (UC), Crohn's Disease (CD)
- EltrekibartLY3041658Phase 22 trials
Eli Lilly · Ulcerative Colitis, Ulcerative Colitis Chronic, Hidradenitis Suppurativa
- HSK47388Phase 22 trials
Haisco Pharmaceutical Group Co., Ltd. · Plaque Psoriasis, Ulcerative Colitis (UC)
- RosnilimabANB030Phase 22 trials
AnaptysBio, Inc. · Rheumatoid Arthritis, Ulcerative Colitis
- SPY001SPY001-001Phase 22 trials
Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis
- SPY002SPY002-091Phase 22 trials
Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis
- SPY003SPY003-207Phase 22 trials
Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis
More on ulcerative colitis: recruiting trials · published research
Related in immunology and inflammation: Rheumatoid arthritis · Plaque psoriasis · Psoriatic arthritis · Atopic dermatitis (eczema) · Crohn's disease · Ankylosing spondylitis · Lupus (SLE) · Hidradenitis suppurativa · Chronic hives (urticaria) · Alopecia areata
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.